Company attributes
Funding Round attributes
Other attributes
Novadip Biosciences is a biotechnology company developing regenerative medicines using stem cells that is headquartered in Mont-Saint-Guibert, Belgium and was founded in 2013 by Jean-François Pollet and Denis Dufrane.
Novadip Biosciences is a company that has created a technology platform known as the 3M3. The platform is designed to be a three dimensional, scaffold-free, and provide adipose-derived stem cells that help restore healing. Their platform was made through fifteen years of academic research, and delivers mRNA and drives the company's product of classic.
The company's manufacturing process includes distribution for its autologous cell therapies. They work from a GMP-certified facility with low starting material variabilities, and provide quality control testing during their process. Their starting material is generally a few cc/mL of adipose human tissue, it goes through a small scale process for expansion, is put through differentiation as a drug substance for several weeks, and finishes at a room temperature for several days.
